<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Global gene expression profiling of highly purified 5q-deleted CD34+CD38(-)Thy1+ cells in 5q- <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (MDSs) supported that they might originate from and outcompete <z:mpath ids='MPATH_458'>normal</z:mpath> CD34+CD38(-)Thy1+ hematopoietic stem cells </plain></SENT>
<SENT sid="1" pm="."><plain>Few but distinct differences in gene expression distinguished <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> stem cells </plain></SENT>
<SENT sid="2" pm="."><plain>Expression of BMI1, encoding a critical regulator of self-renewal, was up-regulated in 5q- stem cells </plain></SENT>
<SENT sid="3" pm="."><plain>Whereas multiple previous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> genetic screens failed to identify altered expression of the gene encoding the myeloid transcription factor CEBPA, stage-specific and extensive down-regulation of CEBPA was specifically observed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> progenitors </plain></SENT>
<SENT sid="4" pm="."><plain>These studies establish the importance of molecular characterization of distinct stages of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem and progenitor cells to enhance the resolution of stage-specific dysregulated gene expression </plain></SENT>
</text></document>